Itral 1%

Itraconazole is an azole antifungal medication approved for the treatment of various systemic and superficial fungal infections in adults, including blastomycosis, histoplasmosis, aspergillosis (in patients intolerant or refractory to amphotericin B), and onychomycosis of the toenails and fingernails caused by dermatophytes. Efficacy and safety have not been established in pediatric patients.[1] It is available in oral capsule (100 mg), oral solution (10 mg/mL), and tablet forms and functions by inhibiting the enzyme 14α-demethylase, which disrupts ergosterol synthesis essential for fungal cell membrane integrity, thereby halting fungal growth.[2][3]